Related Experiment Video

Updated: May 14, 2026

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
10:43

Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Published on: December 23, 2022

Effects of EHD2 interference on migration of esophageal squamous cell carcinoma

Mei Li1, Xiaojing Yang, Jianguo Zhang

  • 1Department of Pathology, Nantong University Cancer Hospital, Nantong, Jiangsu 226001, People's Republic of China.

Medical Oncology (Northwood, London, England)
|January 29, 2013
PubMed

Insights

Reduced C-Terminal EH domain-containing protein 2 (EHD2) expression in esophageal squamous cell carcinoma (ESCC) correlates with increased cell motility and cisplatin resistance. Low EHD2 may indicate a poor prognosis for ESCC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • C-Terminal EH domain-containing protein 2 (EHD2) is a plasma membrane-associated protein.
  • The role of EHD2 in esophageal squamous cell carcinoma (ESCC) and its impact on chemotherapy response remain largely unexplored.

Purpose of the Study:

  • To investigate EHD2 protein expression in human ESCC tissues.
  • To analyze the correlation between EHD2 expression and ESCC cell behavior (motility).
  • To determine the influence of EHD2 expression on the therapeutic efficacy of chemotherapy drugs like cisplatin.

Main Methods:

  • Western blot and immunohistochemistry were employed to quantify EHD2 protein levels in 98 ESCC and adjacent normal tissue samples.
  • In vitro assays, including wound-healing and transwell migration assays, were used to assess cell motility.
  • The expression of the epithelial marker E-cadherin was analyzed in conjunction with EHD2 levels.

Main Results:

  • EHD2 protein levels were significantly reduced in ESCC tissues compared to adjacent normal tissues.
  • Downregulation of EHD2 expression in TE1 ESCC cells enhanced their motility and was associated with decreased E-cadherin expression.
  • Reduced EHD2 expression in TE1 cells conferred resistance to cisplatin treatment.

Conclusions:

  • Low EHD2 expression is implicated in the pathogenesis of esophageal squamous cell carcinoma.
  • EHD2 downregulation contributes to increased ESCC cell motility and chemoresistance.
  • EHD2 may serve as a potential independent prognostic biomarker for poor outcomes in ESCC.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection05:57

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection

Published on: February 10, 2017

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Esophageal Achalasia01:27

Esophageal Achalasia

Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.